Discover one of our 28 local entrepreneurial communities »
Be the first to know as we launch in new countries and markets around the globe.
Interested in bringing MIT Technology Review to your local market?
Unsupported browser: Your browser does not meet modern web standards. See how it scores »
Protein profiles are uncovering weak spots in cancer’s armor.
Genomic technology could accelerate patient trials of new cancer drugs that are targeted to a tumor’s individual molecular profile.
IBM’s Blue Gene supercomputer uncovers a novel drug interaction site.
A biotech company called Cerulean says its nanoparticle-delivered cancer drugs are better at attacking tumors.
The new approach, which features a heat-sensitive fluorescent dye, could eventually replace standard chemotherapy.
By analyzing tumors, Foundation Medicine helps oncologists, pharma companies, and researchers combat the disease.
Researchers are developing more and more genetic tests for specific cancers, but doctors don’t use them as often as they should—a new network of clinics aims to change that.
Researchers look beyond genetics to discover what makes some lung cancer patients respond to certain drugs.